Journal Guide

The European Journal of Oncology Nursing's 2012 Impact Factor is 1.685 (© Thomson Reuters Journal Citation Reports 2013).The European Journal of Oncology Nursing is an international journal which publishes research of direct relevance to patient care, nurse education, management and policy development. EJON is proud to be the official journal of the European Oncology Nursing Society.The journal publishes the following types of papers:• Original research articles• Review articles• Commentaries• Practice Notes• Book and media reviews• A scan of current literatureBenefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com

European Journal of Surgical Oncology's 2012 Impact Factor is 2.614 (© Thomson Reuters Journal Citation Reports 2013).EJSO - European Journal of Surgical Oncology ("the Journal of Cancer Surgery") is the Official Journal of the European Society of Surgical Oncology and BASO ~ the Association for Cancer Surgery.The EJSO aims to advance surgical oncology research and practice through the publication of original research articles, review articles, editorials, debates and correspondence.The Editors welcome submissions on clinical research and all other aspects of surgical oncology which advance the care of patients with cancer, including surgical quality control, epidemiology, preventative aspects of surgical oncology, as well as translational research relevant to surgical oncology practice.

Experimental Cell Research promotes the understanding of cell biology by publishing experimental studies on the general organization and activity of cells. The scope of the journal includes all aspects of cell biology, from the molecular level to the level of cell interaction and differentiation.Experimental Cell Research publishes papers in the area of cell and molecular biology, and papers must provide novel and significant insights into important problems in these areas. Areas of interest include, but are not restricted to:- Apoptosis and programmed cell death- Cancer research- Cell cycle- Cell proliferation and differentiation- Cellular motility and migration- Cell-cell and cell-matrix interaction- Chromatin- Chromosome structure and dynamics- Cytoskeleton- Developmental biology- DNA repair- Epigenetics- Extracellular matrix- Gene regulation- Intracellular trafficking- Mammalian genetic models- Meiosis and mitosis- MicroRNA- Nuclear import-export- RNA processing- Signal transduction- Stem cell biology- Subcellular organizationExperimental Cell Research has partnered with Gastroenterologyhttp://www.gastrojournal.org/ to offer fast track review for certain articles. Articles rejected from Gastroenterology because of their strong biological focus may be directed to ECR for fast track review. Similarly, articles deemed too clinical for ECR and more appropriate for Gastroenterology may be fast tracked through Gastroenterology's review process. Both journals retain editorial independence and reserve the right to request additional changes, re-review, or reject manuscripts.

Experimental Hematology & Oncology is an open access, peer-reviewed online journal that encompasses all aspects of hematology and oncology with emphasis on preclinical, basic, patient-oriented and translational research. The journal acts as an international platform for sharing laboratory findings in these areas and makes a deliberate effort to publish clinical trials with 'negative' results and basic science studies with provocative findings.Experimental Hematology & Oncology aims to publish original work, hypothesis, commentaries and timely reviews in the closely related fields of hematology and oncology.With open access, rapid turnaround time from submission to publication and online live comments from readers, Experimental Hematology & Oncology will strive to be the hub for disseminating new knowledge and discussing controversial topics for both basic scientists and busy clinicians in the field of hematology and oncology.

Expert Review of Anticancer Therapy (ISSN 1473-7140) provides expert appraisal and commentary on the major trends in cancer care and highlights the performance of new therapeutic and diagnostic approaches.Coverage includes tumor management, novel medicines, anticancer agents and chemotherapy, biological therapy, cancer vaccines, therapeutic indications, biomarkers and diagnostics, and treatment guidelines. All articles are subject to rigorous peer-review, and the journal makes an essential contribution to decision-making in cancer care.

Clinical cancer genetics has now matured to a truly multidisciplinary medical discipline in which clinical and molecular geneticists work with clinical and medical oncologists as well as with psycho-social workers.Due to the multidisciplinary nature of clinical cancer genetics most papers are currently being published in a wide variety of journals on epidemiology, oncology and genetics. Familial Cancer provides a forum bringing these topics together, focusing on the interests and needs of the clinician.The journal concentrates on clinical cancer genetics. Most major areas in the field are included, such as epidemiology of familial cancer, molecular analysis and diagnosis, clinical expression, treatment and prevention, counseling and the health economics of familial cancer.

Frontiers of Medicine  is a general medical journal devoted to publishing original research and review articles on the latest advances in clinical and basic medicine with a focus on epidemiology, traditional Chinese medicine, translational research, healthcare, public health and health policies. The journal employs a rigorous peer-review and editing process to ensure the scientific accuracy, novelty and importance of the manuscripts. Frontiers of Medicine is committed to promoting health and health care through communications among professionals in medical care, disease prevention and scientific research throughout the world by updating the progress in medicine, sharing experiences in disease control and treatment and exchanging views on health policies, medical services and health care reform.

Future Oncology takes a forward-looking stance toward the scientific and clinical issues, together with the economic and policy issues that confront us in a new era of cancer care. The journal includes news and views, literature awareness regarding new biomarkers, concise commentary and analysis, reports from the conference circuit and full review articles. Accessible ‘at-a-glance’ formats are important in an increasingly time-constrained clinical community. The article structure has been optimized to make information immediately understandable and accessible.

The GAMO is a high-quality scientific journal (published both in print and freely available online format) that informs healthcare professionals on the most relevant and updated advances on research and education, in order to offer cancer patients multidisciplinary, state of the art care.

It is the official scientific and academic diffusion publication of the Mexican Society of Oncology (SMeO). Regular numbers are published every two months, in addition to several supplements throughout the year.

Its spaces are open to the SMeO members, as well as to any member of the medical community (both national and international) interested in using this publication to communicate his/her works under the standards of universal editorial policies.

It is the jornal of choice for oncologists in matters of research and education on surgical, medical, pediatric, gynecologic, hematologic and radiation oncology, as well as on detection, diagnosis, follow-up and rehabilitation supportive disciplines, fields where different specialties involved in the management of the cancer patient do participate.
About the journal

The mission of the GAMO consists in serving its readers in:

1. representation and promotion of the oncolgy profession throughout the country and the world
2. promotion of standards of the highest quality in the practice of multidisciplinary care for the cancer patient
3. providing educational materials on cancer and support the training of investigators, using printed and electronic media
4. promotion of both clinical and translational cancer research, with special emphasis on clinical trials
5. facilitate the professional development of trainee oncologists and their transition to academical practice, fostering the interest on care for the community
6. promotion of public policies and support and guidance instruments for the cancer patient.

The Editorial Board and Committee are comprised of different experts in the field of oncology from multiple institutions, both national and international. The Editorial Board is structured based on the editorial sections that reflect the contents of the journal. Each section is directed by a section editor who supervises peer reviewing of the works by experts on the relevant area or subject. The Editorial Board Members are regular collaborators of the journal and are appointed to a 2-year period. The Editor in Chief has a 4-year period with option to a second period for the same time.
Publication guidelines

The journal is subject to international publication guidelines that indicate how a manuscript must be prepared to be able to be published, aspects on edition and publication of articles and ethical considerations that have to be followed in the communication of results.
Article types

The journal includes several types of articles. According to the structure, focus, contents, scope and purposes of the document, they can be classified as:

• Editorial
• Original articles
• Review articles
• Clinical cases

The articles can support their proposals, findings and conclusions using tables and images.

The articles are subject to peer review as a control method with regard to quality and veracity of the contents.

Submission: electronic format or by postal mail. The articles are published online in the website and sent to the SMeO members.

Gastric Cancer, a joint official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, publishes significant studies related to stomach neoplasms. The journal welcomes original articles, case reports, short communications, and technical notes, which will be peer-reviewed by the editorial board. Letters to the Editor commenting on articles published in the journal or expressing views on topics concerning gastric cancer are also welcomed. Review articles are in principle solicited by the Editor. Meeting reports will include summaries of symposia or consensus achieved in the congresses of related associations.

Gastrointestinal Tumors is an international, peer-reviewed journal that brings together the leading opinions in all fields related to gastrointestinal cancer research. Ranging from the identification of new therapeutic targets to epidemiology, disease prevention, treatment, and patient management, the journal provides a platform for the dissemination of key opinions and research from thought leaders in the field. By publishing timely reviews and original papers covering the latest developments, the journal helps readers to gain insight into the evolving body of research across the relevant disciplines.

Genes, Chromosomes & Cancer will offer rapid publication of original full-length research articles , perspectives , reviews , letters to the editors , as well as editorial commentaries on genetic analysis as related to the study of neoplasia. Particular emphasis will be placed on work combining molecular and cytogenetic analyses of the genomic alterations of cancer cells. While preference will be given to research using analytical approaches, descriptive studies and case reports will also be welcomed, particularly when they offer insights regarding basic biologic mechanisms or the clinical management of neoplastic disorders. Specific areas covered will include:

Gynecologic Oncology, an international journal, is devoted to the publication of clinical and investigative articles that concern tumors of the female reproductive tract. Investigations relating to the etiology, diagnosis, and treatment of female cancers, as well as research from any of the disciplines related to this field of interest, are published.Research Areas Include:• Cell and molecular biology• Chemotherapy• Cytology• Endocrinology• Epidemiology• Genetics• Gynecologic surgery• Immunology• Pathology• RadiotherapyBenefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services .Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com